These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11567768)

  • 1. Optimal age for vaccination against measles in the State of São Paulo, Brazil, taking into account the mother's serostatus.
    Zanetta RA; Amaku M; Azevedo RS; Zanetta DM; Burattini MN; Massad E
    Vaccine; 2001 Oct; 20(1-2):226-34. PubMed ID: 11567768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team.
    Markowitz LE; Albrecht P; Rhodes P; Demonteverde R; Swint E; Maes EF; Powell C; Patriarca PA
    Pediatrics; 1996 Jan; 97(1):53-8. PubMed ID: 8545224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal measles antibody decay in rural Bangladeshi infants--implications for vaccination schedules.
    de Francisco A; Hall AJ; Unicomb L; Chakraborty J; Yunus M; Sack RB
    Vaccine; 1998 Apr; 16(6):564-8. PubMed ID: 9569466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
    Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À;
    Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity against measles in populations of women and infants in Poland.
    Janaszek W; Slusarczyk J
    Vaccine; 2003 Jun; 21(21-22):2948-53. PubMed ID: 12798638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and Safety of an Early Measles Vaccination Schedule at 6 and 12 Months of Age in Human Immunodeficiency Virus (HIV)-Unexposed and HIV-Exposed, Uninfected South African Children.
    Mutsaerts EAML; Nunes MC; Bhikha S; Ikulinda BT; Boyce W; Jose L; Koen A; Moultrie A; Cutland CL; Grobbee DE; Klipstein-Grobusch K; Madhi SA
    J Infect Dis; 2019 Sep; 220(9):1529-1538. PubMed ID: 31282539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles vaccine immunogenicity and antibody persistence in 12 vs 15-month old infants.
    Johnson CE; Darbari A; Darbari DS; Nalin D; Whitwell J; Chui LW; Cleves MA; Kumar ML
    Vaccine; 2000 May; 18(22):2411-5. PubMed ID: 10738098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles antibodies in women and infants in the vaccine era.
    Kacica MA; Venezia RA; Miller J; Hughes PA; Lepow ML
    J Med Virol; 1995 Feb; 45(2):227-9. PubMed ID: 7775944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel.
    Dagan R; Slater PE; Duvdevani P; Golubev N; Mendelson E
    Pediatr Infect Dis J; 1995 Nov; 14(11):965-9. PubMed ID: 8584363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of alternate immunization regimes for measles in vaccinated populations.
    Pabst HF; Boothe PM; Carson MM
    Vaccine; 1999 Jan; 17(2):182-92. PubMed ID: 9987153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles seroprevalence in pregnant women in Soweto, South Africa: a nested cohort study.
    Gieles NC; Mutsaerts EAML; Kwatra G; Bont L; Cutland CL; Jones S; Moultrie A; Madhi SA; Nunes MC
    Clin Microbiol Infect; 2020 Apr; 26(4):515.e1-515.e4. PubMed ID: 31730905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age.
    De Serres G; Boulianne N; Defay F; Brousseau N; Benoît M; Lacoursière S; Guillemette F; Soto J; Ouakki M; Ward BJ; Skowronski DM
    Clin Infect Dis; 2012 Aug; 55(3):394-402. PubMed ID: 22543023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles.
    De Serres G; Joly JR; Fauvel M; Meyer F; Mâsse B; Boulianne N
    Vaccine; 1997; 15(6-7):620-3. PubMed ID: 9178461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of measles immunity among infants in Maputo City, Mozambique.
    Jani JV; Holm-Hansen C; Mussá T; Zango A; Manhiça I; Bjune G; Jani IV
    BMC Public Health; 2008 Nov; 8():386. PubMed ID: 19014485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroconversion of hepatitis B vaccine in infants related to the mother's serostatus in a community of São José dos Campos, state of São Paulo, Brazil.
    Ribeiro TM; Azevedo RS
    Clinics (Sao Paulo); 2006 Oct; 61(5):387-94. PubMed ID: 17072435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants.
    Pabst HF; Spady DW; Carson MM; Krezolek MP; Barreto L; Wittes RC
    Vaccine; 1999 Apr; 17(15-16):1910-8. PubMed ID: 10217589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.